GlassScriptPhysician profile
Cheril M Bailey
NPI 1427024363
$809.11
in general payments reported to CMS, 2019-2025
10 companies · $102 in 2025
The $102 reported for 2025 was more than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.20 · 2022: $62.60 · 2023: $312 · 2024: $319 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $388.84 | 2022-2025 | Entyvio, Gattex |
| Regeneron Healthcare Solutions, INC. | $69.87 | 2023-2024 | Dupixent |
| Lilly USA, LLC | $56.59 | 2024 | Omvoh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.77 | 2022-2023 | Trulance |
| Janssen Biotech, INC. | $51.52 | 2024-2025 | Tremfya, Stelara |
| Merck Sharp & Dohme LLC | $46.20 | 2024 | Dificid |
| Madrigal Pharmaceuticals | $45.08 | 2025 | Rezdiffra |
| Intercept Pharmaceuticals, INC. | $41.55 | 2021-2023 | Ocaliva |
| E.R. Squibb & Sons, L.L.C. | $29.10 | 2023 | Zeposia |
| Braintree Laboratories, INC. | $26.59 | 2022-2024 | Sutab, Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheril Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.